Our results show a statistically significant positive correlation between POSTN expression in tumor cells and tumor stroma and the expression of the analyzed pro-angiogenic factors (CD31, CD34, CD105, and VEGF-A) and MVD in the entire population of patients with NSCLC and in individual histological subtypes (AC/SCC). The gene discussed is PECAM1; the disease is non-small cell lung carcinoma.